Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | CTSK | P43235 | 3/20 | 0.52 |
| ▸ | CTSH | P09668 | 1/20 | 0.52 |
| ▸ | APLNR | P35414 | 2/20 | 0.47 |
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | CXCL8 | P10145 | 9/20 | 0.46 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7200318 | 0.93 | CTSL (0.49) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL7200319 | 0.93 | CTSL (0.49) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437190 | 0.92 | CTSL (0.62) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31050544 | 0.89 | CTSL (0.53) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437178 | 0.89 | CTSL (0.63) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437180 | 0.89 | CTSL (0.66) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL30366772 | 0.87 | MC4R (0.47) | F2ACEMC4R | |
| SCHEMBL31467769 | 0.83 | CTSL (0.55) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31050545 | 0.83 | MC4R (0.53) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL30015314 | 0.82 | REN (0.53) | APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2025-04-24 | — | — | US | claimed |
| CN-117979954-A | Corticotropin peptide compositions and methods of use | 辉凌有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2025-04-24 | — | — | US | disclosed |
| CN-117979954-A | Corticotropin peptide compositions and methods of use | 辉凌有限公司 | 2024-05-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | MC2R, CRH, NR5A1 | CTSL 2881/4885CTSS 4787/4885CTSK 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.